AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Shareholders Equity (Quarterly) : 47.33B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 47.33B |
| December 31, 2025 | 48.67B |
| September 30, 2025 | 45.89B |
| June 30, 2025 | 44.72B |
| March 31, 2025 | 41.04B |
| December 31, 2024 | 40.79B |
| September 30, 2024 | 40.72B |
| June 30, 2024 | 39.51B |
| March 31, 2024 | 37.44B |
| December 31, 2023 | 39.14B |
| September 30, 2023 | 37.20B |
| June 30, 2023 | 37.39B |
| March 31, 2023 | 35.79B |
| December 31, 2022 | 37.04B |
| September 30, 2022 | 35.13B |
| June 30, 2022 | 35.93B |
| March 31, 2022 | 36.34B |
| December 31, 2021 | 39.27B |
| September 30, 2021 | 39.74B |
| June 30, 2021 | 15.68B |
| March 31, 2021 | 14.43B |
| December 31, 2020 | 15.62B |
| September 30, 2020 | 12.20B |
| June 30, 2020 | 12.24B |
| March 31, 2020 | 10.78B |
| Date | Value |
|---|---|
| December 31, 2019 | 13.13B |
| September 30, 2019 | 12.16B |
| June 30, 2019 | 13.55B |
| March 31, 2019 | 10.48B |
| December 31, 2018 | 12.47B |
| September 30, 2018 | 11.94B |
| June 30, 2018 | 12.64B |
| March 31, 2018 | 12.92B |
| December 31, 2017 | 14.96B |
| September 30, 2017 | 13.72B |
| June 30, 2017 | 13.65B |
| March 31, 2017 | 12.99B |
| December 31, 2016 | 14.85B |
| September 30, 2016 | 13.07B |
| June 30, 2016 | 13.53B |
| March 31, 2016 | 14.74B |
| December 31, 2015 | 18.49B |
| September 30, 2015 | 17.35B |
| June 30, 2015 | 18.28B |
| March 31, 2015 | 16.94B |
| December 31, 2014 | 19.63B |
| September 30, 2014 | 20.44B |
| June 30, 2014 | 22.03B |
| March 31, 2014 | 21.45B |
| December 31, 2013 | 23.22B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GSK Plc | 23.42B |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Novo Nordisk A/S | 33.84B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.02B |
| Total Liabilities (Quarterly) | 66.63B |
| Debt to Equity Ratio | 0.7166 |
| Current Ratio | 0.9092 |
| Net Debt Paydown Yield | -0.12% |